Brain-Computer Interfaces and ALS: Leading Companies, Clinical Trials, and Future Communication Tech

Brain-computer interfaces (BCIs) and ALS are becoming closely connected in both research and real-world use. If you’ve searched what is ALS and wondered how technology can help, BCIs represent one of the most promising advances for people living with ALS, also known as MND, ALS disease, Amyotrophic lateral sclerosis, Motor Neuron disease, or Lou Gehrig’s disease. ALS damages motor neurons, leading to progressive ALS symptoms such as muscle weakness, difficulty speaking, and swallowing problems. In many people—including those with Bulbar ALS—speech can decline early, even while thinking and memory remain strong. That disconnect is where BCI technology matters. A brain-computer interface translates brain signals into commands for a computer or device. Instead of using muscles, a person uses brain activity directly. For advanced ALS stages, BCIs may allow communication even when eye-gaze devices are no longer effective. Several leading companies are driving BCI research in ALS clinical trials. Synchron has implanted minimally invasive devices in people with ALS to enable communication and digital control. Neuralink is developing high-bandwidth implanted BCIs aimed at restoring communication and movement. Blackrock Neurotech has long studied implanted neural arrays used in ALS research settings. People often ask: Can a brain implant help ALS patients speak? and Does BCI change ALS life expectancy or ALS prognosis? BCIs are not an ALS cure and do not stop ALS progression. They do not change ALS causes or whether ALS is genetic, including Familial ALS. But they may preserve communication, autonomy, and dignity. This video is for patients, care partners, families, and medical professionals exploring advanced ALS treatment technologies and the future of assistive innovation.